{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:37:05Z","timestamp":1761989825126,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.survophthal.2015.12.008","type":"journal-article","created":{"date-parts":[[2015,12,29]],"date-time":"2015-12-29T12:49:25Z","timestamp":1451393365000},"page":"512-519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Famous"],"prefix":"10.1016","volume":"61","author":[{"given":"Michelle J.","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Tariq","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Costello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.survophthal.2015.12.008_bib1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1001\/jamaophthalmol.2013.570","article-title":"Cystoid macular edema associated with fingolimod use for multiple sclerosis","volume":"131","author":"Afshar","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2015.12.008_bib2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/WNO.0b013e31829b42e1","article-title":"Fingolimod therapy and macular hemorrhage","volume":"33","author":"Bhatti","year":"2013","journal-title":"J\u00a0Neuroophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2015.12.008_bib3","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1476-5381.2009.00451.x","article-title":"FTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and the central nervous system","volume":"158","author":"Brinkmann","year":"2009","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.survophthal.2015.12.008_bib4","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1001\/jamaophthalmol.2013.47","article-title":"Management of fingolimod-associated macular edema","volume":"131","author":"Chui","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2015.12.008_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/WNF.0b013e3181cbf825","article-title":"Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis","volume":"33","author":"Chun","year":"2010","journal-title":"Clin Neuropharmacol"},{"issue":"5","key":"10.1016\/j.survophthal.2015.12.008_bib6","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1056\/NEJMoa0907839","article-title":"Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis","volume":"362","author":"Cohen","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.survophthal.2015.12.008_bib7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.msard.2012.11.004","article-title":"Severe early bilateral macular edema following fingolimod therapy","volume":"2","author":"Coppes","year":"2013","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.survophthal.2015.12.008_bib8","doi-asserted-by":"crossref","first-page":"134858","DOI":"10.1155\/2013\/134858","article-title":"The afferent visual pathway: designing a structural-functional paradigm of multiple sclerosis","volume":"2013","author":"Costello","year":"2013","journal-title":"ISRN Neurol"},{"issue":"3","key":"10.1016\/j.survophthal.2015.12.008_bib9","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/WNO.0b013e31822bed20","article-title":"Branch retinal vein occlusion during fingolimod treatment in a patient with multiple sclerosis","volume":"31","author":"Gallego-Pinazo","year":"2011","journal-title":"J\u00a0Neuroophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2015.12.008_bib10","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1212\/WNL.0b013e318248deea","article-title":"Fingolimod-associated macular edema: incidence, detection, and management","volume":"78","author":"Jain","year":"2012","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.survophthal.2015.12.008_bib11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMoa0909494","article-title":"A\u00a0placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis","volume":"362","author":"Kappos","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.survophthal.2015.12.008_bib12","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archophthalmol.2010.16","article-title":"Visual field profile of optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial from baseline through 15 years","volume":"128","author":"Keltner","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.12.008_bib13","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1212\/WNL.0000000000000522","article-title":"Axonal loss of retinal neurons in multiple sclerosis associated with optic radiation lesions","volume":"82","author":"Klistorner","year":"2014","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.survophthal.2015.12.008_bib14","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1212\/NXI.0000000000000013","article-title":"Continuing fingolimod after development of macular edema: a case report","volume":"1","author":"Li","year":"2014","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"5566","key":"10.1016\/j.survophthal.2015.12.008_bib15","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1126\/science.1070238","article-title":"Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists","volume":"296","author":"Mandala","year":"2002","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.survophthal.2015.12.008_bib16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrd2356","article-title":"Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules","volume":"8","author":"Marsolais","year":"2009","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"10.1016\/j.survophthal.2015.12.008_bib17","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1167\/iovs.03-0960","article-title":"Role of lysophospholipid growth factors in the modulation of aqueous humor outflow facility","volume":"45","author":"Mettu","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2015.12.008_bib18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1474-4422(05)70071-5","article-title":"Clinically isolated syndromes suggestive of multiple sclerosis, Part 1: natural history, pathogenesis, diagnosis and prognosis","volume":"4","author":"Miller","year":"2005","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.survophthal.2015.12.008_bib19","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamaophthalmol.2013.2465","article-title":"Fingolimod-associated macular edema: resolution by sub-tenon injection of triamcinolone with continued fingolimod use","volume":"131","author":"Minuk","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"1-2","key":"10.1016\/j.survophthal.2015.12.008_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jns.2008.06.031","article-title":"Central nervous system-directed effects of FTY720 (fingolimod)","volume":"274","author":"Miron","year":"2008","journal-title":"J\u00a0Neurol Sci"},{"issue":"5","key":"10.1016\/j.survophthal.2015.12.008_bib21","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1586\/ecp.11.46","article-title":"Potential mechanisms of efficacy and adverse effects in the use of fingolimod (FTY720)","volume":"4","author":"Ontaneda","year":"2011","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.survophthal.2015.12.008_bib22","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1172\/JCI45403","article-title":"Engagement of S1P(1)-degradative mechanisms leads to vascular leak in mice","volume":"121","author":"Oo","year":"2011","journal-title":"J\u00a0Clin Invest"},{"issue":"7","key":"10.1016\/j.survophthal.2015.12.008_bib23","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s12325-015-0224-2","article-title":"Safety and tolerability of fingolimod in Latin American patients with relapsing-remitting multiple sclerosis: the Open-Label FIRST LATAM Study","volume":"32","author":"Ordonez-Boschetti","year":"2015","journal-title":"Adv Ther"},{"issue":"19","key":"10.1016\/j.survophthal.2015.12.008_bib24","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1101\/gad.1227804","article-title":"Sphingosine 1-phosphate receptor regulation of N-cadherin mediates vascular stabilization","volume":"18","author":"Paik","year":"2004","journal-title":"Genes Dev"},{"key":"10.1016\/j.survophthal.2015.12.008_bib25","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S1474-4422(10)70168-X","article-title":"Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis","volume":"9","author":"Petzold","year":"2010","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.survophthal.2015.12.008_bib26","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/eye.2008.117","article-title":"Optic disc cupping after optic neuritis evaluated with optic coherence tomography","volume":"23","author":"Rebolleda","year":"2009","journal-title":"Eye (Lond)"},{"issue":"10","key":"10.1016\/j.survophthal.2015.12.008_bib27","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1177\/1352458514541509","article-title":"Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: yes","volume":"20","author":"Saidha","year":"2014","journal-title":"Mult Scler"},{"key":"10.1016\/j.survophthal.2015.12.008_bib28","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S1474-4422(12)70213-2","article-title":"Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study","volume":"11","author":"Saidha","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.survophthal.2015.12.008_bib29","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/brain\/awq346","article-title":"Primary retinal pathology in multiple sclerosis as detected by\u2028optical coherence tomography","volume":"134","author":"Saidha","year":"2011","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.survophthal.2015.12.008_bib30","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nchembio804","article-title":"Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in\u00a0vivo","volume":"2","author":"Sanna","year":"2006","journal-title":"Nat Chem Biol"},{"issue":"6","key":"10.1016\/j.survophthal.2015.12.008_bib31","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.exer.2009.08.008","article-title":"Sphingosine-1-phosphate effects on the inner wall of Schlemm's canal and outflow facility in perfused human eyes","volume":"89","author":"Stamer","year":"2009","journal-title":"Exp Eye Res"},{"issue":"2","key":"10.1016\/j.survophthal.2015.12.008_bib32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1352458514528759","article-title":"Successful treatment of fingolimod-associated macular edema with intravitreal triamcinolone with continued fingolimod use","volume":"21","author":"Thoo","year":"2015","journal-title":"Mult Scler"},{"issue":"7","key":"10.1016\/j.survophthal.2015.12.008_bib33","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ophtha.2012.12.040","article-title":"Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis","volume":"120","author":"Zarbin","year":"2013","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2015.12.008_bib34","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3892\/etm.2014.1508","article-title":"Clinical characteristics of nonglaucomatous optic disc cupping","volume":"7","author":"Zhang","year":"2014","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.survophthal.2015.12.008_bib35","unstructured":"Hickam's Dictum. https:\/\/en.wikipedia.org\/wiki\/Hickam%27s_dictum"},{"key":"10.1016\/j.survophthal.2015.12.008_bib36","unstructured":"Costello F, Burton J, Lee AG. Neuro-Ophthalmologic Manifestations of Multiple Sclerosis. http:\/\/emedicine.medscape.com\/article\/1214270-overview"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625715300758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625715300758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:44:27Z","timestamp":1758541467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625715300758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0039625715300758"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2015.12.008","relation":{},"ISSN":["0039-6257"],"issn-type":[{"type":"print","value":"0039-6257"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Famous","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2015.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}